Literature DB >> 8641374

Control of adenine nucleotide metabolism and glycolysis in vertebrate skeletal muscle during exercise.

U Krause1, G Wegener.   

Abstract

The turnover of adenosine triphosphate (ATP) in vertebrate skeletal muscle can increase more than a hundredfold during high-intensity exercise, while the content of ATP in muscle may remain virtually unchanged. This requires that the rates of ATP hydrolysis and ATP synthesis are exactly balanced despite large fluctuations in reaction rates. ATP is regenerated initially at the expense of phosphocreatine (PCr) and then mainly through glycolysis from muscle glycogen. The increased ATP turnover in contracting muscle will cause an increase in the contents of adenosine diphosphate (ADP), adenosine monophosphate (AMP) and inorganic phosphate (P(i)), metabolites that are substrates and activators of regulatory enzymes such as glycogen phosphorylase and phosphofructokinase. An intracellular metabolic feedback mechanism is thus activated by muscle contraction. How muscle metabolism is integrated in the intact body under physiological conditions is not fully understood. Common frogs are suitable experimental animals for the study of this problem because they can readily be induced to change from rest to high-intensity exercise, in the form of swimming. The changes in metabolites and effectors in gastrocnemius muscle were followed during exercise, post-exercise recovery and repeated exercise. The results suggest that glycolytic flux in muscle is modulated by signals from outside the muscle and that fructose 2,6-bisphosphate is a key signal in this process.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8641374     DOI: 10.1007/bf01919306

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  38 in total

1.  Metabolic changes in skeletal muscle of frog during exercise and recovery.

Authors:  U Krause; G Wegener
Journal:  Biochem Soc Trans       Date:  1991-04       Impact factor: 5.407

2.  The value of G degrees for the hydrolysis of ATP.

Authors:  J Rosing; E C Slater
Journal:  Biochim Biophys Acta       Date:  1972-05-25

3.  Phosphorus nuclear magnetic resonance of fast- and slow-twitch muscle.

Authors:  R A Meyer; T R Brown; M J Kushmerick
Journal:  Am J Physiol       Date:  1985-03

4.  Control of glycolysis in vertebrate skeletal muscle during exercise.

Authors:  U Krause; G Wegener
Journal:  Am J Physiol       Date:  1996-04

5.  Exercise and recovery in frog muscle: metabolism of PCr, adenine nucleotides, and related compounds.

Authors:  U Krause; G Wegener
Journal:  Am J Physiol       Date:  1996-04

6.  Responses of fatigable and fatigue-resistant fibres of rabbit muscle to low-frequency stimulation.

Authors:  J A Cadefau; J Parra; R Cussó; G Heine; D Pette
Journal:  Pflugers Arch       Date:  1993-09       Impact factor: 3.657

Review 7.  The plasma level of some amino acids and physical and mental fatigue.

Authors:  E A Newsholme; E Blomstrand
Journal:  Experientia       Date:  1996-05-15

8.  Evolution of phosphofructokinase--gene duplication and creation of new effector sites.

Authors:  R A Poorman; A Randolph; R G Kemp; R L Heinrikson
Journal:  Nature       Date:  1984 May 31-Jun 6       Impact factor: 49.962

9.  Activation of muscle phosphofructokinase by fructose 2,6-bisphosphate and fructose 1,6-bisphosphate is differently affected by other regulatory metabolites.

Authors:  K Tornheim
Journal:  J Biol Chem       Date:  1985-07-05       Impact factor: 5.157

10.  Fructose 2,6-bisphosphate, the probably structure of the glucose- and glucagon-sensitive stimulator of phosphofructokinase.

Authors:  E Van Schaftingen; L Hue; H G Hers
Journal:  Biochem J       Date:  1980-12-15       Impact factor: 3.857

View more
  2 in total

Review 1.  Flying insects: model systems in exercise physiology.

Authors:  G Wegener
Journal:  Experientia       Date:  1996-05-15

2.  Comparison of calculated and experimental power in maximal lactate-steady state during cycling.

Authors:  Thomas Hauser; Jennifer Adam; Henry Schulz
Journal:  Theor Biol Med Model       Date:  2014-05-27       Impact factor: 2.432

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.